Latest News

Story

Omnes reinvests in Biosyl

Omnes reinvests in Biosyl

Omnes, through its Omnes Mezzanis 3 fund, has completed its 8th sponsorless deal through its reinvestment in Biosyl, following its previous sponsorless deal with the company in 2019.